Please assess the completion status of the following clinical trial:

Trial Title: Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Smoking an average of at least 10 cigarette per day~* General good health~Exclusion Criteria:~* unstable medical or psychiatric conditions~* history of severe motion sickness~* women who are pregnant or breast feeding~The investigators will evaluate if there are other reasons why someone may not participate

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Nicotine Lozenge Immediately Prior to Stress task (Type: EXPERIMENTAL): Subjects will receive the nicotine lozenge immediately prior to the stress task at one laboratory session and after the stress task at the other laboratory session
- Nicotine lozenge 10 Minutes prior to Stress task (Type: EXPERIMENTAL): Subjects will receive the nicotine lozenge after the stress task during one laboratory session and immediately prior to the stress task at the other laboratory session
- Nicotine lozenge 20 minutes prior to Stress task (Type: EXPERIMENTAL): Subjects will receive the nicotine lozenge after the stress task during one laboratory session and 10 minutes prior to the stress task at the other laboratory session
- Nicotine Lozenge 30 minutes prior to stress taks (Type: EXPERIMENTAL): Subjects will receive the nicotine lozenge 10 minutes prior to the stress task during one laboratory session and after the stress task at the other laboratory session

Based on this trial design, predict the completion outcome and termination type (if applicable).